Enigma Diagnostics Ltd.
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Enigma Diagnostics Ltd.
In Q4 2014 start-ups raised $1.5 billion, a new record. Several companies penned alliances with tech transfer entities; eight start-ups were acquired.
An increasing number of SMEs are going down the joint venture route to establish a presence in the sizeable Chinese healthcare market. In this second instalment of a two-part feature, Tina Tan asks Enigma Diagnostics CEO John McKinley about his experiences of finding the right partner for a joint venture in China.
Setting up a joint venture with a Chinese partner offers one access route. In the first of a two-part feature looking at companies’ experiences breaking into China, Clinica’s Tina Tan speaks to Raymond Akers, executive chairman of Akers Biosciences, to learn about his journey to signing a deal with a Chinese JV partner and the challenges he faced.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced October-November 2014.
Research, Analytical Equipment & Supplies
- PCR & Amplification Tools
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.